Pyrogen testing plays an important role in ensuring the safety of pharmaceuticals, biologics, vaccines, and medical devices by detecting substances that can trigger fever and harmful immune reactions. The global pyrogen testing sector was valued at USD 1.55 billion in 2025, reached USD 1.69 billion in 2026, and is projected to reach USD 3.64 billion by 2035, expanding at a CAGR of 8.91% from 2026 to 2035.
Why Is Pyrogen Testing Becoming More Important?
The growing production of injectable drugs, vaccines, biologics, and advanced therapies is increasing the need for reliable safety testing. Stricter quality requirements and greater focus on patient safety are also encouraging pharmaceutical and biotechnology companies to strengthen testing procedures.
The adoption of animal-free testing methods is another important trend. Recombinant Factor C (rFC) assays and monocyte activation tests (MAT) are gaining attention as alternatives to traditional approaches, offering opportunities for faster and more sustainable testing.
Automation and AI Are Transforming Testing
Automation is helping laboratories improve testing speed, consistency, and accuracy. Automated sample preparation, instrument operation, and data processing can reduce manual errors while supporting high-throughput testing.
AI can further assist with data analysis, quality control, microbial identification, and process monitoring, helping laboratories manage increasingly complex testing requirements.
Consumables and LAL Testing Lead
The consumables segment held the largest share in 2025 because reagents, endotoxin indicators, extraction solutions, and other materials are regularly required for testing.
By test type, the LAL test led with a 45.01% share in 2025. Its established use, sensitivity, and ability to detect bacterial endotoxins have made it an important testing method.
North America Leads the Way
North America accounted for 40.60% of the global share in 2025, supported by advanced pharmaceutical and biotechnology capabilities, strong R&D activity, and established regulatory frameworks.
Asia-Pacific is expected to grow at the fastest pace as pharmaceutical manufacturing, healthcare investment, and biologics production expand across countries such as India, China, and Japan.
Download a Sample Report: https://www.towardshealthcare.com/download-sample/5197
Looking Ahead
The future of pyrogen testing will increasingly depend on automation, animal-free methods, AI-supported analysis, and advanced testing technologies. As pharmaceutical and biotechnology companies develop more complex therapies, efficient and reliable safety testing will remain essential for bringing safer products to patients.
About Us
Healthcare WebWire is a part of Towards Healthcare Research & Consulting which is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: Towards Healthcare Research & Consulting – Expert Consulting Solutions & Research Reports
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium